Inhibikase Therapeutics, Inc. (IKT) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. Welcome to the Inhibit Case Therapeutic Second Quarter 2023 Financial Results Conference Call. All participants will be in listen only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Alex Lobo, Stern Investor Relations. Please go ahead. Good morning and welcome to the Navigate Therapeutics second quarter of 2023 financial results conference call and audio webcast. With me today is Dr. Milton Werner, chief executive officer, chief financial officer. On Monday, August 14, 2023, Inhibit Case issued a press release announcing financial results for the second quarter ended June 30, 2023. We encourage everyone to read yesterday's press release, as well as Inhibit Case's quarterly report on Form 10-Q, which has been filed with the SEC. The company's press release and quarterly report are also available on Inhibit Case's website at inhibitcase.com. In addition, this conference call is being webcast through the investor relations section of the company's website and will be archived there for future reference. Please note that certain information discussed on today's call is covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Participants are cautioned that this conference call contains time sensitive information that is accurate only as of the date of this live broadcast, August 15th, 2023. Actual results could differ materially from those stated or imp...